Literature DB >> 21895219

Pairwise additivity of energy components in protein-ligand binding: the HIV II protease-Indinavir case.

Melek N Ucisik1, Danial S Dashti, John C Faver, Kenneth M Merz.   

Abstract

An energy expansion (binding energy decomposition into n-body interaction terms for n ≥ 2) to express the receptor-ligand binding energy for the fragmented HIV II protease-Indinavir system is described to address the role of cooperativity in ligand binding. The outcome of this energy expansion is compared to the total receptor-ligand binding energy at the Hartree-Fock, density functional theory, and semiempirical levels of theory. We find that the sum of the pairwise interaction energies approximates the total binding energy to ∼82% for HF and to >95% for both the M06-L density functional and PM6-DH2 semiempirical method. The contribution of the three-body interactions amounts to 18.7%, 3.8%, and 1.4% for HF, M06-L, and PM6-DH2, respectively. We find that the expansion can be safely truncated after n=3. That is, the contribution of the interactions involving more than three parties to the total binding energy of Indinavir to the HIV II protease receptor is negligible. Overall, we find that the two-body terms represent a good approximation to the total binding energy of the system, which points to pairwise additivity in the present case. This basic principle of pairwise additivity is utilized in fragment-based drug design approaches and our results support its continued use. The present results can also aid in the validation of non-bonded terms contained within common force fields and in the correction of systematic errors in physics-based score functions.
© 2011 American Institute of Physics

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21895219      PMCID: PMC3182082          DOI: 10.1063/1.3624750

Source DB:  PubMed          Journal:  J Chem Phys        ISSN: 0021-9606            Impact factor:   3.488


  27 in total

Review 1.  Molecular recognition and docking algorithms.

Authors:  Natasja Brooijmans; Irwin D Kuntz
Journal:  Annu Rev Biophys Biomol Struct       Date:  2003-01-28

2.  Comparison of multiple Amber force fields and development of improved protein backbone parameters.

Authors:  Viktor Hornak; Robert Abel; Asim Okur; Bentley Strockbine; Adrian Roitberg; Carlos Simmerling
Journal:  Proteins       Date:  2006-11-15

3.  On sampling of fragment space.

Authors:  Gergely M Makara
Journal:  J Med Chem       Date:  2007-06-14       Impact factor: 7.446

Review 4.  Molecular recognition and drug-lead identification: what can molecular simulations tell us?

Authors:  Giulia Morra; Alessandro Genoni; Marco A C Neves; Kenneth M Merz; Giorgio Colombo
Journal:  Curr Med Chem       Date:  2010       Impact factor: 4.530

5.  Double-mutant cycles: a powerful tool for analyzing protein structure and function.

Authors:  A Horovitz
Journal:  Fold Des       Date:  1996

6.  Formal Estimation of Errors in Computed Absolute Interaction Energies of Protein-ligand Complexes.

Authors:  John C Faver; Mark L Benson; Xiao He; Benjamin P Roberts; Bing Wang; Michael S Marshall; Matthew R Kennedy; C David Sherrill; Kenneth M Merz
Journal:  J Chem Theory Comput       Date:  2011-03-08       Impact factor: 6.006

7.  Energetics of protein-protein interactions: analysis of the barnase-barstar interface by single mutations and double mutant cycles.

Authors:  G Schreiber; A R Fersht
Journal:  J Mol Biol       Date:  1995-04-28       Impact factor: 5.469

8.  Decomposition of the free energy of a system in terms of specific interactions. Implications for theoretical and experimental studies.

Authors:  A E Mark; W F van Gunsteren
Journal:  J Mol Biol       Date:  1994-07-08       Impact factor: 5.469

9.  L-735,524: the design of a potent and orally bioavailable HIV protease inhibitor.

Authors:  B D Dorsey; R B Levin; S L McDaniel; J P Vacca; J P Guare; P L Darke; J A Zugay; E A Emini; W A Schleif; J C Quintero
Journal:  J Med Chem       Date:  1994-10-14       Impact factor: 7.446

10.  Crystal structure at 1.9-A resolution of human immunodeficiency virus (HIV) II protease complexed with L-735,524, an orally bioavailable inhibitor of the HIV proteases.

Authors:  Z Chen; Y Li; E Chen; D L Hall; P L Darke; C Culberson; J A Shafer; L C Kuo
Journal:  J Biol Chem       Date:  1994-10-21       Impact factor: 5.157

View more
  8 in total

1.  The character of molecular modeling.

Authors:  Anthony Nicholls
Journal:  J Comput Aided Mol Des       Date:  2011-12-17       Impact factor: 3.686

2.  Model for the fast estimation of basis set superposition error in biomolecular systems.

Authors:  John C Faver; Zheng Zheng; Kenneth M Merz
Journal:  J Chem Phys       Date:  2011-10-14       Impact factor: 3.488

Review 3.  Fragment-based error estimation in biomolecular modeling.

Authors:  John C Faver; Kenneth M Merz
Journal:  Drug Discov Today       Date:  2013-08-27       Impact factor: 7.851

4.  Prediction of trypsin/molecular fragment binding affinities by free energy decomposition and empirical scores.

Authors:  Mark L Benson; John C Faver; Melek N Ucisik; Danial S Dashti; Zheng Zheng; Kenneth M Merz
Journal:  J Comput Aided Mol Des       Date:  2012-04-04       Impact factor: 3.686

Review 5.  Semiempirical Quantum Mechanical Methods for Noncovalent Interactions for Chemical and Biochemical Applications.

Authors:  Anders S Christensen; Tomáš Kubař; Qiang Cui; Marcus Elstner
Journal:  Chem Rev       Date:  2016-04-13       Impact factor: 60.622

6.  The Effects of Computational Modeling Errors on the Estimation of Statistical Mechanical Variables.

Authors:  John C Faver; Wei Yang; Kenneth M Merz
Journal:  J Chem Theory Comput       Date:  2012-03-12       Impact factor: 6.006

Review 7.  Role of substrate dynamics in protein prenylation reactions.

Authors:  Dhruva K Chakravorty; Kenneth M Merz
Journal:  Acc Chem Res       Date:  2014-12-24       Impact factor: 22.384

8.  Using quantum mechanical approaches to study biological systems.

Authors:  Kenneth M Merz
Journal:  Acc Chem Res       Date:  2014-06-06       Impact factor: 22.384

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.